Venous Thromboembolism – Current Diagnostic and Treatment Modalities

Authors

  • Marijan Bosevski Faculty of Medicine, University Cardiology Clinic Skopje, Macedonia
  • Elizabeta Srbinovska-Kostovska Faculty of Medicine, University Cardiology Clinic Skopje, Macedonia

DOI:

https://doi.org/10.3889/oamjms.2016.087

Keywords:

venous thromboembolism, pulmonary embolism, deep venous thrombosis treatment, novel oral anticoagulants

Abstract

BACKGROUND: Pulmonary embolism and deep venous thrombosis, known as venous thromboembolism (VTE), are associated with a high proportion of morbidity and mortality.

AIM: Aim of this review is to emphasise current diagnostic and therapeutic modalities for VTE.

RESULTS: No differences have been noticed in European and American guidelines in diagnostic approach of this disorder. Today there is enough clinical information for the use of heparin (either, unfractionated or low molecular) and vitamin K antagonists in the treatment of acute and chronic phases of VTE. Novel oral anticoagulants seem to have some advantages in the treatment of this disorder. Rivaroxaban has been approved widespread, for use as a single-drug approach of VTE.

CONCLUSION: Both guidelines are almost similar and good basis for evidence-based treatment of this disorder.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Monreal M, Mahé I, Bura-Riviere A, Prandoni P, Verhamme P, Brenner B, Wells PS, Di Micco P, Bertoletti L. Pulmonary embolism: Epidemiology and registries. Presse Med. 2015;44(12 Pt 2):e377-83. http://dx.doi.org/10.1016/j.lpm.2015.10.006 PMid:26547675

Skhiri M, Hunt SA, Denault AY, Haddad F. Evidence-Based Managеmеnt of Right Heart Failure: a Systematic Review of an Empiric Field. Rev Esp Cardiol. 2010;63(4):451-71. http://dx.doi.org/10.1016/S0300-8932(10)70066-X

Jiménez D, de Miguel-Díez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R, Muriel A, Meyer G, Yusen RD, Monreal M; RIETE Investigators.Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry. J Am Coll Cardiol. 2016;67(2):162-70. http://dx.doi.org/10.1016/j.jacc.2015.10.060 PMid:26791063

Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JR, Wells P, Woller SC, Moores L. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315-52. http://dx.doi.org/10.1016/j.chest.2015.11.026 PMid:26867832

SEC Working Group for the ESC 2014 Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism; Expert Reviewers for the ESC 2014 Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism; SEC Clinical Practice Guidelines Committee. Comments on the 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Rev Esp Cardiol (Engl Ed). 2015;68(1):10-6.

Moliterno DJ, Kristensen SD, De Caterina R. Therapeutic advances in thrombosis. Second edition. Wiley-Blackwel, 2013.

DeLoughery G. Hemostasis and Thrombosis. 3rd Edition. Spinger, 2015. http://dx.doi.org/10.1007/978-3-319-09312-3

Toth PP. Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era. Vasc Health Risk Manag. 2016;12:23-34. http://dx.doi.org/10.2147/VHRM.S88088 PMid:26929637 PMCid:PMC4754098

Martinez K, Kosirog E, Billups SJ, Clark NP, Delate T, Witt DM. Clinical outcomes and adherence to guideline recommendations during the initial treatment of acute venous thromboembolism. Ann Pharmacother. 2015;49(8):869-75. http://dx.doi.org/10.1177/1060028015583892 PMid:25931575

Published

2016-08-24

How to Cite

1.
Bosevski M, Srbinovska-Kostovska E. Venous Thromboembolism – Current Diagnostic and Treatment Modalities. Open Access Maced J Med Sci [Internet]. 2016 Aug. 24 [cited 2024 Mar. 28];4(3):523-5. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2016.087

Issue

Section

F - Review Articles